PubMed:33012868
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 6-9 | Body_part | denotes | Gut | http://purl.org/sig/ont/fma/fma7199 |
| T2 | 139-152 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
| T3 | 618-621 | Body_part | denotes | gut | http://purl.org/sig/ont/fma/fma7199 |
| T4 | 994-997 | Body_part | denotes | gut | http://purl.org/sig/ont/fma/fma7199 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 139-152 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 25-33 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 107-115 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T3 | 291-299 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 435-444 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T5 | 1048-1056 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 6-9 | http://purl.obolibrary.org/obo/UBERON_0001007 | denotes | Gut |
| T2 | 6-9 | http://purl.obolibrary.org/obo/UBERON_0001555 | denotes | Gut |
| T3 | 6-9 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | Gut |
| T4 | 130-131 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T5 | 139-152 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
| T6 | 212-215 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T7 | 463-464 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T8 | 526-527 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 618-621 | http://purl.obolibrary.org/obo/UBERON_0001007 | denotes | gut |
| T10 | 618-621 | http://purl.obolibrary.org/obo/UBERON_0001555 | denotes | gut |
| T11 | 618-621 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | gut |
| T12 | 677-678 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T13 | 823-826 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T14 | 840-841 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T15 | 994-997 | http://purl.obolibrary.org/obo/UBERON_0001007 | denotes | gut |
| T16 | 994-997 | http://purl.obolibrary.org/obo/UBERON_0001555 | denotes | gut |
| T17 | 994-997 | http://www.ebi.ac.uk/efo/EFO_0000834 | denotes | gut |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 267-281 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
| T2 | 267-276 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T3 | 277-281 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T4 | 308-312 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1 | 25-33 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 7 | 107-117 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 8 | 291-299 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 9 | 435-444 | Disease | denotes | infection | MESH:D007239 |
| 10 | 1048-1056 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 11 | 1057-1065 | Species | denotes | patients | Tax:9606 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-34 | Sentence | denotes | Diet, Gut Microbiota and COVID-19. |
| T2 | 35-118 | Sentence | denotes | Worldwide, millions of individuals have been affected by the prevailing SARS-CoV-2. |
| T3 | 119-235 | Sentence | denotes | Therefore, a robust immune system remains indispensable, as an immunocompromised host status has proven to be fatal. |
| T4 | 236-445 | Sentence | denotes | In the absence of any specific antiviral drug/vaccine, COVID-19 related drug repurposing along with various other non-pharmacological measures coupled with lockdown have been employed to combat this infection. |
| T5 | 446-776 | Sentence | denotes | In this context, a plant based rich fiber diet, which happens to be consumed by a majority of the Indian population, appears to be advantageous, as it replenishes the host gut microbiota with beneficial microbes thereby leading to a symbiotic association conferring various health benefits to the host including enhanced immunity. |
| T6 | 777-1131 | Sentence | denotes | Further, implementation of the lockdown which has proven to be a good non-pharmacological measure, seems to have resulted in consumption of home cooked healthy diet, thereby enriching the beneficial microflora in the gut, which might have resulted in better prognosis of COVID-19 patients in India in comparison to that observed in the western countries. |